SWKH Dividend History & Description — SWK Holdings Corp
SWK Holdings focuses on pharmaceutical development, manufacturing and intellectual property licensing business. Co.'s operations comprise two reportable segments: Finance Receivables, which provides customized financing solutions to a range of life science companies, institutions and inventors, and focuses on commercial-stage products and related intellectual property through royalty purchases and financings, as well as through commercialized products; and Pharmaceutical Development, in which through its subsidiary, Enteris BioPharma, Inc., provides formulation solutions built around its proprietary oral drug delivery technologies, the Peptelligence® platform. When considering the SWK Holdings Corp stock dividend history, we have taken known splits into account, such that the SWKH dividend history is presented on a split-adjusted ("apples to apples") basis. SWK Holdings Corp dividend history is presented both in graphical/chart form, and as a SWKH dividend history data table along the right-hand column.